about
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer.Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancer.
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
"Dose dense" chemotherapy in ovarian cancer.
@ast
"Dose dense" chemotherapy in ovarian cancer.
@en
type
label
"Dose dense" chemotherapy in ovarian cancer.
@ast
"Dose dense" chemotherapy in ovarian cancer.
@en
prefLabel
"Dose dense" chemotherapy in ovarian cancer.
@ast
"Dose dense" chemotherapy in ovarian cancer.
@en
P1476
"Dose dense" chemotherapy in ovarian cancer.
@en
P2093
P304
P356
10.1111/J.1525-1438.2005.00438.X
P478
15 Suppl 3
P577
2005-11-01T00:00:00Z